SEDANA — Sedana Medical AB (publ) Income Statement
0.000.00%
Last trade - 00:00
- SEK1.48bn
- SEK1.10bn
- SEK153.87m
- 47
- 18
- 23
- 18
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | SAS | SAS | SAS | SAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 71.6 | 142 | 159 | 123 | 154 |
Cost of Revenue | |||||
Gross Profit | 25.3 | 88.9 | 107 | 86.1 | 109 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 88.8 | 163 | 221 | 229 | 219 |
Operating Profit | -17.2 | -21.4 | -61.5 | -106 | -65.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -16.9 | -24.1 | -57.4 | -72.9 | -59 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16.4 | -27.1 | -58 | -73.5 | -59.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -16.4 | -27.1 | -58 | -73.5 | -59.6 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -16.4 | -27.1 | -58 | -73.5 | -59.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.18 | -0.296 | -0.624 | -0.74 | -0.6 |
Dividends per Share |